Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Frederic Vigant

Showing results (11-20 of 15) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 15 results.
The Journal of Infectious Diseases|November 5, 2016
Cross-Reactive and Cross-Neutralizing Activity of Human Mumps Antibodies Against a Novel Mumps Virus From BatsShannon M Beaty, Raffael Nachbagauer, Ariana Hirsh, et al.
Journal of Virology|November 14, 2014
Efficient reverse genetics reveals genetic determinants of budding and fusogenic differences between Nipah and Hendra viruses and enables real-time monitoring of viral spread in small animal models of henipavirus infectionTatyana Yun, Arnold Park, Terence E Hill, et al.
Journal of Virology|November 30, 2012
Nipah virus envelope-pseudotyped lentiviruses efficiently target ephrinB2-positive stem cell populations in vitro and bypass the liver sink when administered in vivoKarina Palomares, Frederic Vigant, Ben Van Handel, et al.
Nature Communications|May 20, 2016
ISG15 deficiency and increased viral resistance in humans but not miceScott D Speer, Zhi Li, Sofija Buta, et al.
Plos Pathogens|May 3, 2013
A mechanistic paradigm for broad-spectrum antivirals that target virus-cell fusionFrederic Vigant, Jihye Lee, Axel Hollmann, et al.
Pageof 2

Showing results (11-20 of 15) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 15 results.
The Journal of Infectious Diseases|November 5, 2016
Cross-Reactive and Cross-Neutralizing Activity of Human Mumps Antibodies Against a Novel Mumps Virus From BatsShannon M Beaty, Raffael Nachbagauer, Ariana Hirsh, et al.
Journal of Virology|November 14, 2014
Efficient reverse genetics reveals genetic determinants of budding and fusogenic differences between Nipah and Hendra viruses and enables real-time monitoring of viral spread in small animal models of henipavirus infectionTatyana Yun, Arnold Park, Terence E Hill, et al.
Journal of Virology|November 30, 2012
Nipah virus envelope-pseudotyped lentiviruses efficiently target ephrinB2-positive stem cell populations in vitro and bypass the liver sink when administered in vivoKarina Palomares, Frederic Vigant, Ben Van Handel, et al.
Nature Communications|May 20, 2016
ISG15 deficiency and increased viral resistance in humans but not miceScott D Speer, Zhi Li, Sofija Buta, et al.
Plos Pathogens|May 3, 2013
A mechanistic paradigm for broad-spectrum antivirals that target virus-cell fusionFrederic Vigant, Jihye Lee, Axel Hollmann, et al.
Pageof 2